These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 2536980)

  • 1. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an amber mutation in the herpes simplex virus thymidine kinase gene on polypeptide synthesis and stability.
    Irmiere AF; Manos MM; Jacobson JG; Gibbs JS; Coen DM
    Virology; 1989 Feb; 168(2):210-20. PubMed ID: 2536979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Mechanism of Acyclovir Resistance in Herpes Simplex Virus 1, Which Has a UAG Stop Codon between the First and Second AUG Initiation Codons.
    Nguyen PHA; Yamada S; Shibamura M; Inagaki T; Fujii H; Harada S; Fukushi S; Mizuguchi M; Saijo M
    Jpn J Infect Dis; 2020 Nov; 73(6):447-451. PubMed ID: 32611982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance patterns of herpes simplex virus isolates from patients treated with acyclovir.
    McLaren C; Chen MS; Ghazzouli I; Saral R; Burns WH
    Antimicrob Agents Chemother; 1985 Dec; 28(6):740-4. PubMed ID: 3002245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.
    Degrève B; Esnouf R; De Clercq E; Balzarini J
    Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential mechanism of cytostatic effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 9-(1,3-dihydroxy-2-propoxymethyl)guanine, and other antiherpetic drugs on tumor cells transfected by the thymidine kinase gene of herpes simplex virus type 1 or type 2.
    Balzarini J; Bohman C; De Clercq E
    J Biol Chem; 1993 Mar; 268(9):6332-7. PubMed ID: 8384209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A net +1 frameshift permits synthesis of thymidine kinase from a drug-resistant herpes simplex virus mutant.
    Hwang CB; Horsburgh B; Pelosi E; Roberts S; Digard P; Coen DM
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5461-5. PubMed ID: 8202508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of pyrimidine deoxyribonucleoside kinase (thymidine kinase) and thymidylate kinase as a multifunctional enzyme in cells transformed by herpes simplex virus type 1 and in cells infected with mutant strains of herpes simplex virus.
    Chen MS; Summers WP; Walker J; Summers WC; Prusoff WH
    J Virol; 1979 Jun; 30(3):942-5. PubMed ID: 225551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside.
    Tenser RB; Gaydos A; Hay KA
    J Virol; 1996 Feb; 70(2):1271-6. PubMed ID: 8551594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
    Ellis MN; Keller PM; Fyfe JA; Martin JL; Rooney JF; Straus SE; Lehrman SN; Barry DW
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1117-25. PubMed ID: 2821890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification and analysis of thymidine kinase expression from acyclovir-resistant G-string insertion and deletion mutants in herpes simplex virus-infected cells.
    Pan D; Coen DM
    J Virol; 2012 Apr; 86(8):4518-26. PubMed ID: 22301158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of nucleoside analogs by equine herpesvirus type 1 pyrimidine deoxyribonucleoside kinase.
    Kit S; Ichimura H; De Clercq E
    Antiviral Res; 1987 Jan; 7(1):53-67. PubMed ID: 3026247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of extremely low levels of thymidine kinase from an acyclovir-resistant herpes simplex virus mutant supports reactivation from latently infected mouse trigeminal ganglia.
    Besecker MI; Furness CL; Coen DM; Griffiths A
    J Virol; 2007 Aug; 81(15):8356-60. PubMed ID: 17522225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus resistance to antiviral drugs.
    Morfin F; Thouvenot D
    J Clin Virol; 2003 Jan; 26(1):29-37. PubMed ID: 12589832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Wilber BA; Docherty JJ
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1743-7. PubMed ID: 8021603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9L gliosarcoma cells in vitro and in vivo by antiviral agents.
    Kim JH; Kim SH; Kolozsvary A; Brown SL; Kim OB; Freytag SO
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):861-8. PubMed ID: 7591895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
    Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
    Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
    Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
    Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.